Comparison of permanent <sup>125</sup>I seeds implants with two different techniques in 500 cases of prostate cancer

Jose Luis Guinot; Jose Vicente Ricós; Maria Isabel Tortajada; Miguel Angel Santos; Juan Casanova; Jose Clemente; Josefa Samper; Paula Santamaría; Leoncio Arribas

doi:10.5114/jcb.2015.53525

eISSN: 2081-2841
ISSN: 1689-832X

Journal of Contemporary Brachytherapy

Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links

Editorial System

Submit your Manuscript

4/2015
vol. 7

Send email

Copy url:

abstract:

Original paper

Comparison of permanent ¹²⁵I seeds implants with two different techniques in 500 cases of prostate cancer

Jose Luis Guinot

,

Jose Vicente Ricós

,

Maria Isabel Tortajada

,

Miguel Angel Santos

,

Juan Casanova

,

Jose Clemente

,

Josefa Samper

,

Paula Santamaría

,

Leoncio Arribas

J Contemp Brachytherapy 2015; 7, 4: 258-264

DOI: https://doi.org/10.5114/jcb.2015.53525

Online publish date: 2015/08/18

View full text Get citation

Purpose: To perform a comparative study of 500 consecutive ¹²⁵I seeds implants for intracapsular prostate carcinoma with two techniques differing in terms of both strand implantation and planning.

Material and methods: From 2002 to 2007 we performed 250 implants with fixed stranded seeds (RapidStrand™) and a preplanning system and from 2007 to 2010, 250 with real-time and ProLink™ system. Mean age was 68 and 66, respectively, median PSA (prostate-specific antigen) 7.3 and 7.2, stage T1-T2a in 98% and 94%, and Gleason ≤ 6 in 96% and 86%. Low risk cases were 81% and 71%. The prescribed dose was 145 Gy to the prostate volume, or 108 Gy plus EBRT 46 Gy in some intermediate risk cases. Hormonal treatment was given to 42% and 28%.

Results: Median follow-up was 48 and 47 months, respectively, 14 patients in the first group and 7 patients in the second developed biochemical failure (BF). Actuarial biochemical relapse-free survival (bRFS) at 5 years increased from 90.2% to 97.2% (low risk from 91.3% to 97.2%, intermediate risk from 84.2% to 97.1%). Biochemical failure was independent of hormone treatment. Rectal complications were G1-2 in 1.2% and 5.2%, respectively. A urinary catheter was necessary in 6.9% and 9.6%, and urethral resection in 1.9% and 4.4%. Genitourinary toxicity was G1-2 in 4.6% and 12%, G3-4 in 1.9% and 4.8%. An assessment of mean D90 in a sample of patients showed that the dosimetry in postoperative planning based on CT improved from a mean D90 of 143 Gy to 157 Gy.

Conclusions: The outcome of patients with low risk prostate carcinoma treated with ¹²⁵I seed is very good with low complications rate. The real-time approach in our hands achieved a more precise seed implantation, better dosimetry, and a statistically non-significant better biochemical control. We have made this our standard technique.

keywords:

Comparison of permanent 125I seeds implants with two different techniques in 500 cases of prostate cancer

Jose Luis Guinot , Jose Vicente Ricós , Maria Isabel Tortajada , Miguel Angel Santos , Juan Casanova , Jose Clemente , Josefa Samper , Paula Santamaría , Leoncio Arribas

LDR brachytherapy, permanent, prostate cancer, real-time, seeds, technique

Comparison of permanent ¹²⁵I seeds implants with two different techniques in 500 cases of prostate cancer

Jose Luis Guinot

,

Jose Vicente Ricós

,

Maria Isabel Tortajada

,

Miguel Angel Santos

,

Juan Casanova

,

Jose Clemente

,

Josefa Samper

,

Paula Santamaría

,

Leoncio Arribas